RECRUITING

Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study evaluates how new magnetic resonance imaging (MRI) and artificial intelligence techniques improve the image quality and quantitative information for future prostate MRI exams in patients with suspicious of confirmed prostate cancer. The MRI and artificial intelligence techniques developed in this study may improve the accuracy in diagnosing prostate cancer in the future using less invasive techniques than what is currently used.

Official Title

Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification

Quick Facts

Study Start:2021-04-01
Study Completion:2027-06-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04765150

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:MALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Male patients 18 years of age and older
  2. * Clinical suspicion of prostate cancer or biopsy-confirmed prostate cancer
  3. * Undergone or undergoing multi-parametric 3 T prostate MRI at the University of California at Los Angeles (UCLA)
  4. * Ability to provide consent
  1. * Contraindications to MRI (e.g., cardiac devices, prosthetic valves, severe claustrophobia)
  2. * Contraindications to gadolinium contrast-based agents other than the possibility of an allergic reaction to the gadolinium contrast-based agent
  3. * Prior radiotherapy

Contacts and Locations

Study Contact

Nashla Barroso
CONTACT
(310) 794-7952
nbarroso@mednet.ucla.edu

Principal Investigator

Kyung H Sung, PhD
PRINCIPAL_INVESTIGATOR
UCLA / Jonsson Comprehensive Cancer Center

Study Locations (Sites)

UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, 90095
United States

Collaborators and Investigators

Sponsor: Jonsson Comprehensive Cancer Center

  • Kyung H Sung, PhD, PRINCIPAL_INVESTIGATOR, UCLA / Jonsson Comprehensive Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-04-01
Study Completion Date2027-06-01

Study Record Updates

Study Start Date2021-04-01
Study Completion Date2027-06-01

Terms related to this study

Additional Relevant MeSH Terms

  • Prostate Carcinoma